Enlivex Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Enlivex Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Enlivex Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Enlivex Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Enlivex Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Enlivex Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Enlivex Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management Fund III L.P.(15.1%),Pontifax Management III G.P. (2011) Ltd.(15.1%), etc.
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Udi Gilboa(0%)
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Udi Gilboa(14.0%)
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Israel III L.P.(15.2%),Pontifax Cayman III L.P.(15.2%), etc.
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Visium Asset Management, LP(0%),JG Asset, LLC(0%), etc.
Enlivex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
No Data
No Data